Lansforsakringar Fondforvaltning AB publ Purchases 1,777 Shares of CME Group Inc. $CME

Lansforsakringar Fondforvaltning AB publ raised its position in shares of CME Group Inc. (NASDAQ:CME) by 1.6% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 114,411 shares of the financial services provider’s stock after buying an additional 1,777 shares during the period. Lansforsakringar Fondforvaltning AB publ’s holdings in CME Group were worth $30,913,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of CME. Amundi raised its holdings in shares of CME Group by 24.0% during the second quarter. Amundi now owns 1,987,347 shares of the financial services provider’s stock valued at $548,150,000 after acquiring an additional 385,225 shares in the last quarter. Truist Financial Corp raised its holdings in CME Group by 8.9% in the 3rd quarter. Truist Financial Corp now owns 70,712 shares of the financial services provider’s stock worth $19,106,000 after purchasing an additional 5,773 shares in the last quarter. Alley Investment Management Company LLC lifted its position in shares of CME Group by 86.0% in the 3rd quarter. Alley Investment Management Company LLC now owns 29,223 shares of the financial services provider’s stock worth $7,896,000 after purchasing an additional 13,512 shares during the period. Elevate Capital Advisors LLC boosted its stake in shares of CME Group by 85.2% during the 3rd quarter. Elevate Capital Advisors LLC now owns 8,519 shares of the financial services provider’s stock valued at $2,302,000 after purchasing an additional 3,919 shares in the last quarter. Finally, Victory Financial Group LLC boosted its stake in shares of CME Group by 310.2% during the 2nd quarter. Victory Financial Group LLC now owns 3,044 shares of the financial services provider’s stock valued at $839,000 after purchasing an additional 2,302 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Stock Up 1.4%

Shares of NASDAQ:CME opened at $308.09 on Monday. The company has a current ratio of 1.03, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The stock has a fifty day simple moving average of $283.19 and a two-hundred day simple moving average of $274.74. CME Group Inc. has a 12-month low of $246.91 and a 12-month high of $309.35. The stock has a market capitalization of $111.10 billion, a price-to-earnings ratio of 27.61, a PEG ratio of 3.60 and a beta of 0.27.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share for the quarter, beating the consensus estimate of $2.75 by $0.02. The firm had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.64 billion. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The company’s revenue was up 8.1% on a year-over-year basis. During the same period last year, the company earned $2.52 earnings per share. On average, research analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, March 26th. Stockholders of record on Tuesday, March 10th will be paid a $1.30 dividend. This is a boost from CME Group’s previous quarterly dividend of $1.25. This represents a $5.20 annualized dividend and a dividend yield of 1.7%. The ex-dividend date is Tuesday, March 10th. CME Group’s payout ratio is currently 44.80%.

Analyst Ratings Changes

A number of equities analysts recently issued reports on CME shares. UBS Group reissued a “neutral” rating and issued a $310.00 price target on shares of CME Group in a research note on Friday, February 6th. TD Cowen increased their target price on CME Group from $305.00 to $328.00 and gave the stock a “buy” rating in a research report on Thursday, February 5th. The Goldman Sachs Group raised their target price on CME Group from $264.00 to $266.00 and gave the company a “sell” rating in a research note on Monday, February 9th. Argus reduced their price target on CME Group from $308.00 to $295.00 in a research note on Friday, October 31st. Finally, Bank of America increased their price objective on CME Group from $201.00 to $209.00 in a report on Wednesday, December 10th. Nine investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $299.53.

More CME Group News

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME’s formal announcement to offer 24/7 trading for crypto futures and options — a move that addresses the timing gap with always‑on spot crypto markets and could lift ADV and fee revenue; the company cited record crypto notional volume in 2025. CME Group to Launch 24/7 Cryptocurrency Futures and Options Trading on May 29
• Positive Sentiment: Widespread coverage emphasizes the practical impacts — continuous trading can reduce “CME gaps,” boost institutional flow and expand crypto derivatives ADV, supporting the bullish thesis for trading‑fee growth. CME targets May launch for 24/7 crypto derivatives trading
• Positive Sentiment: Analyst/fin‑media bullishness — some outlets include CME among top picks, arguing the firm converts market volatility into trading revenue, which supports the stock’s rally. 2 Best Stocks to Buy Right Now for February
• Neutral Sentiment: Macro/market context — broader market moves (small‑cap rotation and sector flows) could be influencing intraday moves in financials/exchanges but are not specific to CME’s fundamentals. Small Caps Stage Quiet Comeback As AI Trade Shows Cracks
• Neutral Sentiment: Reported short‑interest data appears immaterial or inconsistent (no meaningful change reported); it isn’t currently signaling a large positioning risk.
• Negative Sentiment: Insider selling — director Martin J. Gepsman sold 300 shares; small in size but noteworthy as a disclosed insider sale. Insider Sale: Martin J. Gepsman
• Negative Sentiment: Critical takeaways — at least one outlet warns of risks to the CME thesis (valuation and competitive/operational risks), which could temper enthusiasm if amplified by further negative coverage. 2 Reasons CME is Risky and 1 Stock to Buy Instead

Insider Activity

In other CME Group news, Director Martin J. Gepsman sold 300 shares of the stock in a transaction on Friday, February 20th. The stock was sold at an average price of $305.90, for a total transaction of $91,770.00. Following the sale, the director directly owned 24,999 shares in the company, valued at approximately $7,647,194.10. This trade represents a 1.19% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director William R. Shepard purchased 251 shares of the firm’s stock in a transaction dated Tuesday, December 30th. The stock was acquired at an average price of $278.37 per share, with a total value of $69,870.87. Following the purchase, the director directly owned 258,710 shares of the company’s stock, valued at approximately $72,017,102.70. The trade was a 0.10% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last ninety days, insiders have sold 26,048 shares of company stock worth $7,054,920. Corporate insiders own 0.30% of the company’s stock.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.